NYSE$ELV

Elevance Health Inc · Q2 2021 earnings

Q2 2021 earnings · · Investor relations

Briefing

Anthem reported strong financial performance in the second quarter of 2021 and raised full-year outlook.

Anthem, Inc. reported a 14.1% increase in operating revenue to $33.3 billion and GAAP net income of $7.25 per share for the second quarter of 2021. Medical enrollment reached 44.3 million members, and the company raised its full-year adjusted net income outlook to greater than $25.50 per share.

  • GAAP net income was $7.25 per share, including net positive adjustment items of $0.22 per share; adjusted net income was $7.03 per share.
  • Operating revenue grew by 14.1% over the prior quarter to $33.3 billion, or 15.8% adjusted for the repeal of the health insurance tax.
  • Medical enrollment increased by 1.9 million members year over year and 820 thousand members in the second quarter to 44.3 million members.
  • Full year adjusted net income outlook raised from greater than $25.10 per share to greater than $25.50 per share.

Headline financials

Total Revenue

$33.9B

Previous: $29.3B+15.7%
EPS (adj)

$7.03

Previous: $9.20-23.6%
Total Medical Membership

44.3M

Previous: 42.5M+4.2%
Capital Expenditures

-$489M

Previous: -$437M-11.9%
Free Cash Flow

$1.3B

Previous: $1.84B-29.1%
Net Income

$1.79B

Previous: $2.28B-21.2%
Operating Income

$2.08B

Previous: $3.36B-38.1%
Gross Profit

$31.2B

Previous: $27B+15.5%
Cash & Equivalents

$5.26B

Previous: $6.03B-12.8%
Total Assets

$96.1B

Previous: $88B+9.2%
Stock-Based Comp

$69M

Previous: $67M+3.0%

Revenue & EPS history

Elevance Health · Revenue · Quarterly

$33.9B

Q2 2021+15.7%vs Q2 2020
Beat estimate in 13 of 16 quarters(81%)
ActualEstimate

Revenue by segment

Elevance Health · $36.7B total across 1 segment · Q3 2023

  • Health Benefits
    $36.7B

Forward guidance

Anthem expects GAAP net income to be greater than $24.89 per share and adjusted net income to be greater than $25.50 per share for the full year 2021. Medical membership is expected to be in the range of 44.8 - 45.3 million and operating revenue is expected to be approximately $137.1 billion.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2021

Historical avgQ2 2021

-0.1%

Avg return

Earnings day

+0.8%

Avg return

5 days after

+2.4%

Avg return

30 days after

54%

25 / 46 earnings

Positive

+11.1%

Q4 2018

Best reaction

-15.0%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+2.3%+8.5%+20.3%
Q4 2025+5.1%+5.9%-0.9%
Q3 2025-1.1%-3.3%-11.3%
Q2 2025+0.3%+6.0%+5.9%
Q1 2025+2.1%+3.7%-5.5%
Q4 2024+2.9%+3.8%-1.4%
Q3 2024-15.0%-15.5%-19.4%
Q2 2024-8.7%-8.9%-1.7%
Q1 2024+4.1%+4.7%+7.6%
Q4 2023+1.8%+3.0%+8.9%
Q3 2023-0.6%-3.0%-0.6%
Q2 2023+7.2%+6.2%+4.3%
Q1 2023-5.8%-4.2%-5.2%
Q4 2022+3.6%+2.2%-0.1%
Q3 2022+2.0%+10.1%+3.6%
Q2 2022-7.6%-5.3%+1.2%
Q1 2022+1.1%-2.0%-4.7%
Q4 2021-0.8%+0.4%+3.3%
Q3 2021+9.3%+10.4%+5.5%
Q2 2021-1.4%-2.9%-3.1%
Q1 2021-0.5%-1.1%+3.7%
Q4 2020-3.8%-6.4%-3.0%
Q3 2020-8.6%-6.9%+4.7%
Q2 2020+4.5%+2.1%+4.5%
Q1 2020+4.7%+1.0%+9.7%
Q4 2019-8.4%-8.2%-11.4%
Q3 2019-0.3%+2.9%+12.1%
Q2 2019-2.9%-1.4%-13.9%
Q1 2019+2.1%+6.2%+10.6%
Q4 2018+11.1%+11.6%+12.8%
Q3 2018+0.2%+1.4%+9.3%
Q2 2018+0.4%+2.5%+7.8%
Q1 2018+5.3%+4.9%+3.3%
Q4 2017+0.2%-5.3%-4.3%
Q3 2017+6.0%+7.3%+12.9%
Q2 2017-3.7%-2.3%+1.1%
Q1 2017+3.4%+3.9%+6.2%
Q4 2016+2.3%+1.7%+7.7%
Q3 2016+2.2%+5.2%+23.6%
Q2 2016-3.4%-7.3%-9.2%
Q1 2016-2.1%
Q4 2015-8.2%
Q3 2015-2.3%
Q2 2015+0.4%
Q1 2015-2.1%
Q4 2014-0.5%
Q3 2014
Q2 2014
Q1 2014
Q4 2013
Q3 2013
Q2 2013
Q1 2013
Q4 2011
Q4 2012
Q3 2012
Q2 2012
Q1 2012
Q3 2011
Q2 2011
Q1 2011
Q4 2010
Q3 2010
Q2 2010
Q1 2009
Q1 2010
Q4 2007
Q4 2009
Q3 2009
Q3 2008
Q4 2008
Q2 2009
Q2 2008

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro